Alterity Therapeutics (ASX:ATH) has completed the Phase 2 clinical trial in multiple system atrophy for ATH434, its lead drug ...

COSOL (ASX:COS) has announced the acquisition of Toustone Pty Ltd, an Australian data analytics firm, for up to $22.4m ...

Shares in Salesforce (NYSE: CRM) surged more than 10% in after-hours trading following the release of the company's fiscal Q3 2025 earnings report.

Cash EBITDA of $33m to $36m, up from $28m to $32m. EBITDA of $41m to $44m, revised from $36m to $40m. Revenue of $240m to $245m, increased from $235m to $240m.

Australia’s economy grew by 0.3% in the September quarter 2024, marking the slowest annual growth rate since late 2020.